Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Alkermes’ Lumryz hits Phase 3 mark in another sleep disorder, momentum accelerates with $2.4 billion Avadel acquisition
By healthadmin
Marking a quick clinical win with its $2.37 billion acquisition of Avadel, Alkermes reported on…
Pfizer and Alvinas receive $85 million upfront in Rigel license agreement for new breast cancer drug Vepanu
By healthadmin
Pfizer and Alvinas have found a buyer for their newly approved breast cancer drug Vepanu,…
Since Roche launched Babismo, a long-acting eye disease treatment, in 2022, Bayer and Regeneron have…
Scientists have discovered a molecular “switch” in mice that turns on an energy-burning system hidden…
SkillCare, a manufacturer of specialty healthcare products, on Tuesday announced the launch of the SkillCare…
“Infancy,” Dr. Oz said, is the name of a disease that affects one in three…
Researchers at the University of Missouri are developing a new method to remove microscopic plastic…
Are the benefits of psychedelics overstated? New study highlights issue of selection bias
By healthadmin
A study comparing psychedelic enthusiasts and the general public (those who have had psychedelic experiences)…
Older people who cut back on fat in their diets and reduced their intake of…
European Union advances plan to strengthen manufacturing autonomy and avoid drug shortages
By healthadmin
With positive momentum building on plans for the second half of 2025, European Union legislators…